DARA BioSciences, Inc. Will Present at Singular Research Conference November 1

Published: Oct 30, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today it will present at the Singular Research seventh annual “Best of the Uncovereds” Conference on Thursday, November 1 in Los Angeles. DARA just launched its second product in five months (Soltamox®, the only FDA-approved oral liquid version of tamoxifen citrate), and is planning a third product launch for first quarter of 2013.

Back to news